Amplification of the lytic potential of effector/memory CD8+ cells by vector-based enhancement of ICAM-1 (CD54) in target cells: implications for intratumoral vaccine therapy.

Amplification of the lytic potential of effector/memory CD8+ cells by vector-based enhancement of ICAM-1 (CD54) in target cells: implications for intratumoral vaccine therapy.

Item
http://www.wikidata.org/entity/Q40518046
Potent anti-tumor effects of a dual specific oncolytic adenovirus expressing apoptin in vitro and in vivoPrognostic value of serum CD44, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 levels in patients with indolent non-Hodgkin lymphomas.Induction of higher-avidity human CTLs by vector-mediated enhanced costimulation of antigen-presenting cells.Combination chemotherapy and radiation of human squamous cell carcinoma of the head and neck augments CTL-mediated lysis.The use of chelated radionuclide (samarium-153-ethylenediaminetetramethylenephosphonate) to modulate phenotype of tumor cells and enhance T cell-mediated killingInhibition of the angiopoietin/Tie2 axis induces immunogenic modulation, which sensitizes human tumor cells to immune attack.Combining radiation and immunotherapy for synergistic antitumor therapy.Virus-based therapies for colon cancer.Immunological suppression of head and neck carcinoma by dendritic cell tumor fusion vaccine.E2F1 renders prostate cancer cell resistant to ICAM-1 mediated antitumor immunity by NF-κB modulation.Recent advances in the use of therapeutic cancer vaccines in genitourinary malignancies.Turning T cells on: epigenetically enhanced expression of effector T-cell costimulatory molecules on irradiated human tumor cells.Cytokine-armed vaccinia virus infects the mesothelioma tumor microenvironment to overcome immune tolerance and mediate tumor resolution.Phase I study of intraprostatic vaccine administration in men with locally recurrent or progressive prostate cancer.
P2860

Amplification of the lytic potential of effector/memory CD8+ cells by vector-based enhancement of ICAM-1 (CD54) in target cells: implications for intratumoral vaccine therapy.

Item
http://www.wikidata.org/entity/Q40518046
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Amplification of the lytic pot ...... intratumoral vaccine therapy.
@en
type
label
Amplification of the lytic pot ...... intratumoral vaccine therapy.
@en
prefLabel
Amplification of the lytic pot ...... intratumoral vaccine therapy.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P6179
P698
P356
P1433
P1476
Amplification of the lytic pot ...... intratumoral vaccine therapy.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P6179
P698